Polypid Ltd share price logo

Polypid Ltd Share Price

NASDAQ: PYPD

Small Cap

$3.40

+0.01

(+0.29%)

Live

as on

Polypid Ltd Stock Performance

as on September 16, 2025 at 11:36 pm IST

  • Day's Low

    Day's High

    $3.35
    $3.54
    downward going graph

    1.47%

    Downside

    4.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.3
    $3.93
    downward going graph

    32.35%

    Downside

    15.59%

    Upside

    downward going graph

Polypid Ltd share price movements today

Previous Close
$3.39
Open
$3.53
Volume
336.3K
Day's Low - High
$3.35 - $3.54
52 Week Low - High
$2.3 - $3.93

Polypid Ltd Historical Returns

1 Month Return
-1.74 %
3 Month Return
-7.63 %
1 Year Return
-4.64 %
3 Year Return
-90.89 %
5 Year Return
-99.16 %

Polypid Ltd Stock Fundamentals & Key Indicators

Check Polypid Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$55.2M

EPS (TTM)

-2.4475

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-31.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

7610200.00%

Polypid Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Polypid Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$55.2M-99.16%NA0.00%
BUY$61.1B251.26%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.2B47.46%28.0931.86%
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Polypid Ltd Stock including INR - Dollar returns

The Polypid Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Polypid Ltd investment value today

Current value as on today

₹1,00,373

Returns

₹373

(+0.37%)

Returns from Polypid Ltd Stock

₹4,494 (-4.49%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Polypid Ltd Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Polypid Ltd. Average target price of $12.5

Polypid Ltd Share Price Target

Get share price movements and forecasts by analysts on Polypid Ltd.

What analysts predicted

72.8%UPSIDE

Target Price

$12.5

Current Price

$3.4

Analyzed by

9 Analysts

Target

$12.50

Polypid Ltd target price $12.5, a slight upside of 72.8% compared to current price of $3.4. According to 9 analysts rating.

Polypid Ltd Stock's Interest Amongst Investors

Search interest for Polypid Ltd Stock has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-86% versus previous 30 day period

Polypid Ltd Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
5
-5
-5
-5
-6
-6
-7
-8
-7
-9
EBITDA
-5
-5
-5
-5
-6
-6
-7
-8
-7
-9
Interest Expense
11
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-6
-5
-5
-6
-6
-6
-7
-8
-8
-9
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-6
-5
-5
-6
-6
-6
-7
-8
-8
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Polypid Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-1
-1
-1
-1
-1
Operating Income
-10
-13
-18
-18
-26
-42
-38
-22
-28
EBITDA
-10
-13
-42
-5
-25
-41
-37
-20
-25
Interest Expense
1
40
0
0
0
87
1
1
1
Depreciation
-
0
0
0
1
1
1
1
1
Income Before Tax
-11
-54
5
-6
-36
-42
-39
-23
-28
Income Tax Expense
1
40
-24
-11
-1
-1
0
0
0
Net Income
-11
-54
5
4
-35
-40
-39
-23
-29
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Polypid Ltd Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-5
-5
-6
-6
-6
-7
-8
-8
-9
Operating Cash Flow
-
-
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
Change in Cash
-2
-2
3
-
-
-
-
-
-

Polypid Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-11
-54
5
-6
-36
-42
-39
-23
-29
Operating Cash Flow
-9
-12
-16
-17
-21
-32
-34
-17
-21
Investing Cash Flow
-8
-8
10
-23
-40
36
16
3
0
Financing Cash Flow
26
14
9
37
62
1
16
9
32
Change in Cash
8
-6
3
-3
0
5
-1
-3
10

Global Institutional Holdings in Polypid Ltd

Funds
Holdings
AIGH Capital Management, LLC
7.51%
Rosalind Advisors, Inc.
6.4%
Dafna Capital Management LLC
1.83%
J. Goldman & Co LP
0.81%
ADAR1 Capital Management LLC
0.5%

Insights on Polypid Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 207.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 75.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, PYPD stock has moved down by -90.9%

About Polypid Ltd

polypid®, a specialty pharmaceutical company, develops and manufactures products based on its plex™ technology. so far, 70 patients have been treated in clinical trials with polypid’s anti-infection products demonstrating safety and efficacy. polypid is in the process of submitting its lead product for phase-iii trial in the us and eu. plex™ is able to optimize drugs'​ therapeutic performance and clinical outcomes. plex™-based protected drug reservoir is implanted directly into the body’s target area thus enabling prolonged delivery of drugs, over periods ranging from days to several months. polypid’s pipeline focuses on 3 products: d-plex™ - intended for prevention and treatment of surgical infections caused by bacteria. its effectiveness is currently being tested in patients undergoing open-heart surgery, with a view to preventing infections that may occur following surgery. the product is currently undergoing clinical studies at several medical centers. bonypid®-1000 - designed to e
OrganisationPolypid Ltd
Headquarters18 Hasivim Street, Petah Tikva, Israel, 4959376
IndustryHealth Technology
CEOMs. Dikla Czaczkes Akselbrad
E-voting on sharesClick here to vote

Key Management of Polypid Ltd

Name

Title

Dr. Nurit Tweezer-Zaks M.B.A., M.D.

Chief Medical Officer

Ms. Dikla Czaczkes Akselbrad

CEO & Director

Mr. Jonny Missulawin

Chief Financial Officer

Ms. Dalit Hazan

Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs

Mr. Tal Vilnai

General Counsel & Corporate Secretary

Ms. Rivi Lev-ari

Vice President of Human Resource

Dr. Jean-Marc Hagai Pharm.D.

Chief Commercial Officer

Mr. Ori Warshavsky

Chief Operating Officer - US

Ms. Maria Rubin

Executive Vice President of Operations

FAQs

What is Polypid Ltd share price today?

Polypid Ltd share price today is $3.4 as on . Polypid Ltd share today touched a day high of $3.54 and a low of $3.35.

What is the 52 week high and 52 week low for Polypid Ltd share?

Polypid Ltd share touched a 52 week high of $3.93 on and a 52 week low of $2.3 on . Polypid Ltd stock price today i.e. is trending at $3.4,which is 13.49% down from its 52 week high and 47.83% up from its 52 week low.

What is Polypid Ltd's market capitalisation today?

Polypid Ltd market capitalisation is $0.00T as on .

How to invest in Polypid Ltd Stock (PYPD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Polypid Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Polypid Ltd Shares that will get you 0.4412 shares as per Polypid Ltd share price of $3.4 per share as on September 16, 2025 at 11:36 pm IST.

What is the minimum amount required to buy Polypid Ltd Stock (PYPD) from India?

Indian investors can start investing in Polypid Ltd (PYPD) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Polypid Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Polypid Ltd share’s latest price of $3.4 as on September 16, 2025 at 11:36 pm IST, you will get 2.9412 shares of Polypid Ltd. Learn more about fractional shares .

What are the returns that Polypid Ltd has given to Indian investors in the last 5 years?

Polypid Ltd stock has given -99.16% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?